Top compounds associated with response to OR4K13

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	SN-38	GDSC1000	pan-cancer	AAC	-0.03	0.4
mRNA	ML050	CTRPv2	pan-cancer	AAC	-0.032	0.4
mRNA	SNX-2112:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.028	0.4
mRNA	Erlotinib	GDSC1000	pan-cancer	AAC	0.042	0.4
mRNA	sitagliptin	CTRPv2	pan-cancer	AAC	-0.062	0.4
mRNA	TW 37	GDSC1000	pan-cancer	AAC	-0.029	0.4
mRNA	selumetinib:piperlongumine (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.03	0.4
mRNA	JQ-1:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.029	0.4
mRNA	ML083	CTRPv2	pan-cancer	AAC	-0.033	0.4
mRNA	BRD-K04800985	CTRPv2	pan-cancer	AAC	-0.032	0.4

Download CSV